Stock Market Recap: Beam Therapeutics Inc (BEAM) Concludes at 23.15, a -2.11 Surge/Decline

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $23.65 in the prior trading day, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $23.15, down -2.11%. In other words, the price has decreased by -$2.11 from its previous closing price. On the day, 1.03 million shares were traded. BEAM stock price reached its highest trading level at $23.46 during the session, while it also had its lowest trading level at $22.69.

Ratios:

Our goal is to gain a better understanding of BEAM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.81 and its Current Ratio is at 5.81. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.

On July 23, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $80.

JP Morgan Upgraded its Neutral to Overweight on January 29, 2024, whereas the target price for the stock was revised from $38 to $40.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 14 ’24 when Ciaramella Giuseppe sold 51,110 shares for $26.27 per share. The transaction valued at 1,342,752 led to the insider holds 160,260 shares of the business.

Giuseppe Ciaramella bought 102,220 shares of BEAM for $2,519,723 on Oct 14 ’24. On Oct 07 ’24, another insider, Burrell Terry-Ann, who serves as the Officer of the company, bought 185,565 shares for $23.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 1907921152 and an Enterprise Value of 987247936. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.41 while its Price-to-Book (P/B) ratio in mrq is 2.23. Its current Enterprise Value per Revenue stands at 2.8 whereas that against EBITDA is -6.061.

Stock Price History:

Over the past 52 weeks, BEAM has reached a high of $49.50, while it has fallen to a 52-week low of $16.95. The 50-Day Moving Average of the stock is -6.43%, while the 200-Day Moving Average is calculated to be -14.00%.

Shares Statistics:

The stock has traded on average 928.99K shares per day over the past 3-months and 994530 shares per day over the last 10 days, according to various share statistics. A total of 81.63M shares are outstanding, with a floating share count of 71.66M. Insiders hold about 13.06% of the company’s shares, while institutions hold 81.49% stake in the company. Shares short for BEAM as of 1727654400 were 11356434 with a Short Ratio of 12.22, compared to 1724976000 on 11082269. Therefore, it implies a Short% of Shares Outstanding of 11356434 and a Short% of Float of 18.049999.

Most Popular